021-51111890
购物车（）
sales@molnova.cn
Perospirone hydrochloride
CAS No. 129273-38-7
Perospirone hydrochloride ( SM-9018 hydrochloride;Perospirone HCl )
产品货号. M21176 CAS No. 129273-38-7
Perospirone hydrochloride is an atypical antipsychotic agent for the treatment of schizophrenia. ?It also displays affinity towards 5HT1A receptors as a partial agonist.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ￥316 | 有现货 |
|
| 25MG | ￥518 | 有现货 |
|
| 50MG | ￥753 | 有现货 |
|
| 100MG | ￥1110 | 有现货 |
|
| 200MG | ￥1596 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Perospirone hydrochloride
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Perospirone hydrochloride is an atypical antipsychotic agent for the treatment of schizophrenia. ?It also displays affinity towards 5HT1A receptors as a partial agonist.
-
产品描述Perospirone hydrochloride is an atypical antipsychotic agent for the treatment of schizophrenia. ?It also displays affinity towards 5HT1A receptors as a partial agonist.
-
同义词SM-9018 hydrochloride;Perospirone HCl
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT
-
研究领域Neurological Disease
-
适应症schizophrenia
化学信息
-
CAS Number129273-38-7
-
分子量463
-
分子式C23H31ClN4O2S
-
纯度>98% (HPLC)
-
溶解度DMSO:92 mg/mL (198.68 mM)
-
SMILESCl.O=C1C2CCCCC2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Murata Y Bundo M Sunaga F et al. DNA Methylation Profiling in a Neuroblastoma Cell Line Exposed to the Antipsychotic Perospirone[J]. Pharmacopsychiatry 2018:s-0044-101467.
产品手册
关联产品
-
Ziprasidone hydrochl...
A full antagonist of D2 and 5-HT2A receptors with Ki of 6.8 and 0.6 nM, respectively; also is a partial agonist of 5-HT1A, and a partial antagonist of 5-HT2C and 5-HT1D receptors.
-
SB 242084 hydrochlor...
SB 242084 is a potent, selective, brain penetrant 5-HT2C receptor antagonist.
-
PF-05212377
PF-05212377 (SAM-760, PF 5212377) is a potent and selective 5-HT6 receptor antagonist with potential therapy for the symptomatic treatment of mild to moderate Alzheimer's disease.
